No association between HIV disease and its treatment and thyroid function

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• Thyroid dysfunction is a known complication in various chronic illnesses.
• Human Immunodeficiency Virus (HIV) infection and its treatment can potentially impact thyroid function.

Purpose of the Study:

• To determine the prevalence of overt and subclinical thyroid disease in HIV-positive patients.
• To identify risk factors for thyroid dysfunction, including highly active antiretroviral therapy (HAART).
• To assess the longitudinal occurrence of thyroid dysfunction over three years.

Main Methods:

• Retrospective analysis of thyroid function tests (TFTs) in a cohort of HIV-positive patients.
• Inclusion of patients with normal TFTs but a history of thyroid disease.
• Multivariate analysis to identify associated risk factors.

Main Results:

• Low prevalence of overt hypothyroidism (2.5%) and hyperthyroidism (<1%).
• Prevalence of subclinical hypothyroidism (4%) and hyperthyroidism (<1%).
• No significant association found between HAART, specific antivirals, and overt hypothyroidism.

Conclusions:

• Overt thyroid disease is uncommon in this HIV-positive cohort.
• Routine thyroid screening may not be warranted for all HIV-positive individuals.
• Further research could explore subclinical thyroid dysfunction and nonthyroidal illness in this population.